Cargando…
eP488: Patient-centric adaptations for pheNIX clinical trial evaluating HMI-102 gene therapy in adults with PKU in the era of COVID-19
Autores principales: | Donahue, Joseph, White, Yvonne, Sandhu, Avner, Fairley, Cecilia, Haroldson, Jeffrey, Kaufman, Jon, Jarlenski, Donna, Cohn, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935063/ http://dx.doi.org/10.1016/j.gim.2022.01.520 |
Ejemplares similares
-
Adaptation and Validation of a Questionnaire to Evaluate Knowledge of the Low Phe Diet in PKU
por: Ramos-Álvarez, Rodolfo, et al.
Publicado: (2021) -
People and the HMI of the Future
por: Kellermann, Timm, et al.
Publicado: (2020) -
PHENIX Overview
por: Rosati, Marzia
Publicado: (2020) -
phenix.mr_rosetta: molecular replacement and model rebuilding with Phenix and Rosetta
por: Terwilliger, Thomas C., et al.
Publicado: (2012) -
Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control
por: de Sonneville, Leo M. J., et al.
Publicado: (2011)